The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia platforms.

The Connecticut resident said she’s a woman of strong faith who believes in the power of prayer and that’s all that helped to ...

Patients with relapsed/refractory multiple myeloma could benefit from repeat treatment with drugs their disease has ...

Our additional preliminary studies demonstrate that dual targeting of multiple myeloma cells and BM-CAFs by CAR-T cells is ...

Multiple Myeloma, a cancer of the plasma cells in the bone marrow, is the third most common blood cancer in Europe. Despite recent advanced in treatment that has increased survival, it is still an ...

Multiple myeloma (MM) is an incurable blood cancer, leading to weakened immunity, bone damage, and other serious health ...

Prognostic Factors for Survival in Multiple Myeloma Patients That Receive Bispecific Antibodies: Does Relative Dose Intensity Matters? Dr. Emmanuel Bugarin-Estrada is a co-author. Evaluating the ...

In suspected autoimmune (perhaps "autosensitive" is a preferable term) 9 diseases, such as multiple sclerosis, in which the specific antigen (or antigens) is unknown, response of lymphocytes in ...

One of the major recent advances in the study of immune responses has been the recognition of the important role of lymphocytes. A great deal of effort has gone into the development of methods to ...

To open multiple folders at once on Windows 11/10 computer, there are two methods, and both of them share some differences. Open all the folders in separate windows Open one folder in the current ...

Over the past 2 decades, treatment options for multiple myeloma have increased dramatically. That's led to an uptick in survival rates. While there’s still no cure for this blood cancer ...

Multiple myeloma is considered to be relapsed if symptoms of the disease appear after a time of improvement. It’s considered to be refractory when it gets worse even though it’s being treated.